An SVI-led research team has been awarded a National Health and Medical Research Council Ideas Grant to tackle one of the most persistent challenges faced by people with a heritable condition called Fanconi anaemia: identifying its genetic causes to improve diagnosis and care.
Dr Prerak Trivedi from SVI’s Immunology & Diabetes Unit has been named one of seven recipients of a Breakthrough T1D Early Career Basic Researcher Fellowship.
An international study has revealed that tiny fragments of RNA play a critical role in keeping the immune system in check, opening new possibilities for treating autoimmune diseases like lupus, psoriasis and rheumatoid arthritis.
SVI researcher Dr Steve Foulkes has earned international recognition for research that is reshaping how clinicians understand exercise intolerance in people affected by cancer and heart disease.
SVI PhD student Mary Louise Fac has taken home the Roger Melick Young Investigator Award from the Australia and New Zealand Bone and Mineral Society (ANZBMS).
The SVI Foundation is welcoming respected Australian leader Paul Ramadge to its Board, highlighting his breadth of experience across media, education, international collaboration and philanthropy.
SVI researchers Associate Professor Ramin Shayan and Dr Tara Karnezis are helping establish the new Centre of Research Excellence (CRE) for Lymphoedema and Lymphatic Regeneration.
SVI is welcoming DNA damage and repair researcher Dr Rebecca Smith, thanks to funding from the Cancer Council Victoria’s Cancer Research Fellowship Victoria Program, announced today.
The National Health and Medical Research Council (NHMRC) is highlighting the far-reaching impact of Australian medical research through a new series of case studies, developed in partnership with leading institutions across the country.
This year’s student-led BioMed Link Conference brought together around 80 biomedical science students from 15 institutions, creating a vibrant space for connection, collaboration and skill-building across universities.
SVI researchers have made a breakthrough in understanding why children with Fanconi anaemia (FA) develop life-threatening bone marrow failure – while also showing that cutting-edge gene-editing technologies may one day offer a safer, more effective treatment.
PhD student Kezia Gitareja is studying a new way to stop multiple myeloma, a type of blood cancer that affects the cells in our bone marrow.
SVI had the honour of hosting Professor Sir Philip Cohen, a scientist whose discoveries have shaped modern biology, for a special seminar this week.
Scientists studying the fat-tailed dunnart, a tiny Australian marsupial, have uncovered genetic clues that explain how different mammals develop their facial features.
Building on SVI research from the BANDIT trial, Eli Lilly has announced the launch of the BARICADE Phase 3 trials.
Through her raffle fundraiser, Jedda Hindmarsh is helping to drive awareness, advance scientific discovery, and give hope to others living with lipoedema.
Once a champion trainer on the track, Jack Holt became a champion for medical research – a race for cures that continues today.
Dr Chirantani Mukherjee is working to understand how Fanconi anaemia develops at the genetic level to design better diagnostics and, ultimately, better treatments.
SVI paid tribute to more than three decades of extraordinary dedication from its SVI Support Group, marking a milestone moment in the Institute’s history.
A breakthrough led by SVI’s Carmelo Cerra and Dr. Jian Kang has uncovered how certain ovarian cancer cells survive treatment, and more importantly, how they can be eliminated.